Вы находитесь на странице: 1из 74

-

www.nicorandil.ru
1



[2]:

10 .
[1], :
42 % [2].
:
2 % [1]
2-3 % [1]


44%


29%



27%

[1] - . . (2- ).
2008; 7(6); . 4: 7
[2] - 2010


10 .
[1], 2010 :
2 % [2]
1638 . / [2]

() 77,5% [3].
50% 65
[4].

[1] - . . (2- ).
2008; 7(6); . 4: 7
[2] - 2010
[3] .., .., .. .. .
CLARIFY. 2013; 8: 28-33
[4] .., ... : // 3- ., 2012

[16] - Chambless L et al. Population versus clinical view of case fatality from acute coronary heart disease: Results from the WHO MONICA
Project 1985 1990: Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation 1997; 96: 3849 3859
[17] - Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe: Task Force of the European Society of
Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18: 1231 1248.

1. ( )
2.
2.1. :
2.1.1. .
2.1.2. ( I IV)
2.1.3. ()
2.2. (, , )
3.
3.1. ()
3.2.
4.
5. ( )

, 1984, ,1979

70%
60%

62%

57%

50%
35%

40%
30%
20%
10%
0%



10-20 4 1 :

10-15%
10-15%

70-80%



.., .. . . , 2002, 110
.., .., .., .. . .
. .: , 2006, 386


60%

,
() 10-30 4 6
( 20%)
( ),
, , ( 40%)
[1]
-5- 20-40 /
[2].
70% -5- (5-) 20% -2- [3].
[1] - . . . 2009; 8(6); . 4: 12
[2] - Kohli RS, et al. Acute and sustained effects of isosorbide 5-mononitrate in stable angina pectoris. Am J Cardiol. 1986 Oct 1;58(9):727-31
[3] - .. . : // 7 10, 2012:24-7


1976 -
1984 -
1994 -
2009 - ( -)

:
,

() ( 5 ; )

: ,

( )

10


, [1]
, ,

11 ,
20 2 8
[2]

. - CONSILIUM MEDICUM ()
2012 14 10: 101-107
K. Stoschitzky1, et al. No evidence of nitrate tolerance with Nicorandil. Poster session 3.Citation: European Heart Journal 2012;Vol.32(Abstract
Supplement):470

11

12

13
Horinaka S.Use of nicorandil in cardiovascular disease and its optimization.Drugs. 2011 Jun 18;71(9):1105-19

NO

14
Horinaka S.Use of nicorandil in cardiovascular disease and its optimization.Drugs. 2011 Jun 18;71(9):1105-19


, .., ,
, :


,
.

15

16
Horinaka S.Use of nicorandil in cardiovascular disease and its optimization.Drugs. 2011 Jun 18;71(9):1105-19


(eNOS)

17


, 2013

1-
+

-
/

+-
> 2

1-

2-

**

*

*

*-

**-

The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. 2013 ESC guidelines on the management of stable 18
coronary artery disease. European Heart Journal (2013) 34, 29493003 ( : http://www.scardio.ru/content/Guidelines/IBS_rkj_7_14.pdf).




2011

21. :
21.5. -
()
( I. B),
( IONA).

19


ST :
. 2014
8.13.
(20 ),
(10-20 3 /) .
( ESC , 2013; :
II, ).
..
IONA (Impact Of Nicorandil in Angina), 5126
, 66% , ,
/ -
17% (=0,014), 21% (=0,028) 15% (=0,021).
OACIS (Osaka Acute Coronary
Insufficiency Study) c 1846 (87% ST), ,
,

50,5% (=0,0393).

20

: ST :
. , 2014; 1 (www.rosokr.ru)

- -

, -

( )

21


()

- -

-
, ..

-, -,


22

3
,
28 , 50%, I , 230
/, 160/95 2 , 585 ,
n=42
,
n=12
(5 3 /, n=21) () (20 2
/, n=21)
23
Sekiya M, et al. J Cardiovasc Pharmacol. 2005 Jul;46(1):63-7

24
Sekiya M, et al. J Cardiovasc Pharmacol. 2005 Jul;46(1):63-7

25
Sekiya M, et al. J Cardiovasc Pharmacol. 2005 Jul;46(1):63-7

10
2
18 : (32,3%),
(23%), (46%), (0 %),
(0%); n=232
2 50 : 1-
5 3 (n=115), 2-
20 2 (n=117)
26
Zhu WL, et al. Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered
nicorandil in patients with stable angina pectoris in China // Circ J. 2007 Jun;71(6):826-33

20,3%

50% 2 :

27
Zhu WL, et al. Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered
nicorandil in patients with stable angina pectoris in China // Circ J. 2007 Jun;71(6):826-33

,
-5 III

, ,
12
III , 50 59
, n=100
2 50 : 1-
10 3 , 2- -5-
(-5-) 50 /

28
.. . -5- // :
. 12, 2 (70), 2013: 83-7

29
.. . -5- // :
. 12, 2 (70), 2013: 83-7

30
.. . -5- // :
. 12, 2 (70), 2013: 83-7

31
.. . -5- // :
. 12, 2 (70), 2013: 83-7


-:

, , , ,
..
,
(, .),


( )
32
.., ... : // 3- ., 2012

- -

()

: ,

33

( ,
)

( )

()

, -
( )

: ,

( )

34

,
6-12
(, , ), ( ,
) (, , )
,

35
. - // CONSILIUM MEDICUM
() 2012 14 10: 101-107

,
,

36
. - // CONSILIUM MEDICUM
() 2012 14 10: 101-107



II III

, ,
3
II III , 45 78 ,
n=67
10 / 2
2 . 1- (n=30)
20 3 , 2- (n=37) 10 /
1020 ,

37
.. .
// : . 12, 2 (70), 2013: 75-82

.. .

// : . 12, 2 (70), 2013: 75-82

38



7,7
63% 4 :
70%

63,4%

, %

60%
50%
40%
30,8%
30%
20%
10%

5,9%

0%

. . 2008; 5: 30-35.

1-3

39

. . 2008; 5: 30-35.

40



II-III ,
50 2 , n=120
-
12
8
II-III
50 2
, n=120: 88 32 32
82 1 34 .
10 2 , 2 20 2

- -

41


: .., .., .. ().
- . ().
, ( .., .., ..)
( ..)
( .., .., .., .., ..,
.., .., .., .., .., ..)
( .., .., .., .., ..)
( .., .., ..)
( .., .., ..)
( .., ..)
( .., .., .., ..)
( .., .., ..)
( .., ..)
- ( .., .., .., .., ..,
..)
( .., ..)
- -

42


(1:1)


(
50 2 /)

10-14

10 2 /

20 2 /


SEL

-1

-0

-2

- , ,

- -

-6

[12] - -
[4] .. . -5-
. : . 12, 2 (70), 2013: 83-7

44


- 2-
,
,

45


12

[12] , -

46

- -

-
, .. ,
2015
(65%) ,
(20%)

- -

()

47

- -

()

QT

48


If -

, . BEAUTIFUL
,
, ( , ()
=0,05. SHIFT , ,
< 35% 18%
: - ,
.

()


49


-
IONA (the Impact Of Nicorandil in Angina)
-
200
1 3 , 1,6 0,5
( ) : (57%),
(55%), (77%), (57%),
(88%), 45 , 55 , n=5126
10 2 , 2 20 2

50
The IONA Study Group // Lancet 2002;359:1269-75

IONA
17% ,

(=0,014)
- ()

:

13,1%

15,5%

,
,

51
The IONA Study Group // Lancet 2002;359:1269-75

IONA
21%
(=0,028)
-
()

():

,
,

52
The IONA Study Group // Lancet 2002;359:1269-75

IONA
14% -
(=0,027)
-
()

( ):

- ,
,
,


53
The IONA Study Group // Lancet 2002;359:1269-75

IONA


95% ,
18- . . NNT ,

54
The IONA Study Group // Heart 2004;90:1427-30


2009
8.1.9.2.
IONA ,

. . . 2009;
8(6); . 4: 38

55

-

JCAD (Japanese Coronary Artery Disease)
, , ()

13000
( 75%
), (28,4%) (14,8%) ,
(21,4%), (28,3%)
- - (10,3%); 67 (27-94)
2 ,
n=5116

2,7
155
56
Horinaka S. . // 2011; 2 (88): 82-90

JCAD



-
()

( ):





HR -

57
Horinaka S. . // 2011; 2 (88): 82-90

JCAD



-
()

:

HR -

58
Horinaka S. . // 2011; 2 (88): 82-90

JCAD
56%

100%



():

75%

50%

- 56%
25%
<0.01

0%
,
n=82

,
n=68
59

Horinaka S. . // 2011; 2 (88): 82-90

JCAD
-

2,7
:

( , =0.03)

-71%


( , =0.0042)

-64%
-56%

(
, =0.0022)

-56%

( ,
=0.0001)

-33%
-35%
, %
Horinaka S. . // 2011; 2 (88): 82-90

(
, =0.014)

(
, =0.0008)

60

61
Terkelsen CJ, et al. Mortality rates in patients with ST-elevation vs.non-ST-elevation acute myocardial infarction: observations from an unselected
cohort // Eur Heart J. 2005 Jan;26(1):18-26

... . , .
. 2011; 1: 24-27
.. . ( ,
). . 2.
// 2012;8(6): 738-745

62



OACIS (Osaka Acute Coronary Insufficiency Study)
, ()

25
340 1088 , 709
5 ( 2005 2009 .)
24 ,
,
n=1846

63
. .
// 2012 5 (97): 90-97

OACIS


() :

(, .)
64

. .
// 5 (97) 2012

OACIS


:

65
. .
// 2012 5 (97): 90-97

OACIS


, , 75


, %


5 . :

100
90
80
70
60
50
40
30
20
10
0

- 71%

- 57%
=0,0298

- 53%
=0,0472

=0,0471

<75 , n=1242

, n=1180

, n=1394

66
. .
// 2012 5 (97): 90-97

, , n=138
I ( 0,1 /)
100 /, 75 /,
( )
5 , per os 2
: (n=47),
10 (n=45), 20 (n=46)
-

Yang J, et al Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention.
Anadolu Kardiyol Derg. 2015 Feb;15(2):125-31.

67



(per os 2 )
I ( 20-24
) , n=138 ( ):

p=0.049

- 48%

Yang J, et al Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention.
Anadolu Kardiyol Derg. 2015 Feb;15(2):125-31.

68


I per os 2
(per os 2 )
I ( 20-24 )
, n=138 ( -):

p=0.046

Yang J, et al Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention.
Anadolu Kardiyol Derg. 2015 Feb;15(2):125-31.

69

,

CESAR 2
(the Centralised European Studies in Angina and Revascularisation)
, , -
14
48
, (79%)
, (70% ,
), (50%), 48,9 72,5 , n=188
: 180-360 /, 50-100 /
12,5-50 3 , 150 /,

20 2 48
70
Patel D et al.// Eur Heart J 1999; 20: 51 57

CESAR 2

71
Patel D et al.// Eur Heart J 1999; 20: 51 57

CESAR 2

72
Patel D et al.// Eur Heart J 1999; 20: 51 57

CESAR 2

73
Patel D et al.// Eur Heart J 1999; 20: 51 57


:
10 - 20 2 - 3

:
20

www.nicorandil.ru

74